Louisville Doctor Pays Fine for Violating Controlled Substances Act
AUG 05 -- LOUISVILLE, KY – On July 29, 2010, Ronald J. Hamm, M.D., of Louisville, entered into a settlement agreement with the United States Government, requiring him to pay $120,000 to resolve potential civil claims in connection with his alleged violations of the federal Controlled Substances Act. Dr. Hamm owns and operates the Hameron Weight Loss Centers, located at 11901 Shelbyville Road and 5512 Bardstown Road in Louisville, and at 3016 Charleston Crossing Way in New Albany, Indiana. He routinely prescribes controlled substances for his weight loss patients and is required to register the location of each of his clinics with the U.S. Drug Enforcement Administration (“DEA”), and to comply with all applicable federal laws.
In August 2009, the DEA inspected the Hameron Weight Loss Centers located on Shelbyville Road and in New Albany. During that inspection, the DEA cited Dr. Hamm for several violations of the Controlled Substances Act, including: failure to take and maintain initial and biennial inventories of certain drugs; failure to maintain purchase receipts of drugs and a running log of drugs dispensed; failure to register the New Albany location with the DEA; and failure to provide adequate physical security for certain drugs stored at the Shelbyville Road clinic.
Federal law imposes civil monetary penalties for violations such as those noted during the DEA’s inspection of Dr. Hamm’s clinics. Dr. Hamm has agreed to pay $120,000 to resolve the United States’ potential civil claims concerning those violations.
This matter was handled by Assistant United States Attorney L. Jay Gilbert and was investigated by the DEA’s Drug Diversion Section.